Relationship Between Baseline and Early Changes in C‐Reactive Protein and Interleukin‐6 Levels and Clinical Response to Tocilizumab in Rheumatoid Arthritis

OBJECTIVE: To clarify the relevance of measuring interleukin‐6 (IL‐6) and C‐reactive protein (CRP) levels in order to predict clinical response to tocilizumab (TCZ) in rheumatoid arthritis patients. METHODS: In a pooled, post hoc analysis of 5 pivotal trials of TCZ, we examined the distributions of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jianmei, Devenport, Jenny, Low, Jason M., Yu, Dale, Hitraya, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120137/
https://www.ncbi.nlm.nih.gov/pubmed/26473986
http://dx.doi.org/10.1002/acr.22765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120137/
https://www.ncbi.nlm.nih.gov/pubmed/26473986
http://dx.doi.org/10.1002/acr.22765

Ejemplares similares